Noze
Early disease diagnostics through an AI-powered sense of smell.
Early disease diagnostics through an AI-powered sense of smell.
Noze is a pioneering startup that has revolutionized disease diagnostics through the application of AI-powered olfactory technology. Founded in 2015 and headquartered in Canada, the company has gained recognition as the global leader in digital odor perception. Noze's cutting-edge digital nose, which leverages exclusively licensed NASA technology, distinguishes itself through its unprecedented accuracy in detecting and identifying odors in real-world settings. The company's mission is underscored by its commitment to enhancing human health and wellbeing through the facilitation of real-time disease detection at any point-of-care. One of the pivotal achievements for Noze was securing a grant investment from the Bill & Melinda Gates Foundation on 28th March 2024. This investment solidifies the company's position as a frontrunner in the development of breath-based odor biomarkers for the improvement of patient outcomes.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $5.00M | 1 |
|
30 Jul 2024 |
| Grant | Unknown | 1 |
|
28 Mar 2024 |
| Grant | $1.00M | 1 |
|
14 Mar 2023 |
| Series A | $13.20M | 1 | BDC Venture Capital | 10 Mar 2022 |
| Convertible Note | $1.25M | 1 |
|
01 Dec 2020 |
No recent news or press coverage available for Noze.
We care about your data, and we'd love to use cookies make your experience better.
